This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: University of Pennsylvania. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Cory Alvey: Innovator in Cancer Therapy
Introduction
Cory Alvey is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of cancer therapy through his innovative research and inventions. With a total of 2 patents, Alvey is dedicated to developing novel methods for treating cancer.
Latest Patents
Cory Alvey's latest patents focus on compositions and methods for selective phagocytosis of human cancer cells. The first patent describes a phagocytic cell modified with a repressor of signal regulatory protein-alpha (SIRPα) and bound to a targeting antibody. This modification enhances the phagocytic activity of the cell toward tumor tissue. The invention aims to provide novel therapies in cancer treatment. Additionally, methods of enhancing phagocytic activity and treating tumors are included in this patent.
Career Highlights
Alvey is affiliated with the University of Pennsylvania, where he conducts his research and develops his inventions. His work is pivotal in advancing cancer therapies and improving patient outcomes.
Collaborations
Cory Alvey collaborates with esteemed colleagues, including Dennis E Discher and Kyle R Spinler. Their combined expertise contributes to the innovative research being conducted at the University of Pennsylvania.
Conclusion
Cory Alvey is a dedicated inventor whose work in cancer therapy is making a significant impact. His innovative approaches and collaborations are paving the way for new treatments that could benefit many patients in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile